ClinicalTrials.Veeva

Menu
G

Grupo Elora Centro de Pesquisa e Ensino em Saude de Santa Catarina | Hospital Baia Medical Center

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

JNJ-79635322
Daratumumab
Pomalidomide
Pasritamig
Teclistamab
Dexamethasone
Macitentan

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 5 total trials

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma (TRIlogy-4)

The purpose of this study is to evaluate how well JNJ-79635322 works when compared with an anti-B-cell maturation antigen (BCMA)xCD3 bispecific antib...

Enrolling
Multiple Myeloma
Drug: JNJ-79635322
Drug: Teclistamab

The purpose of this study is to evaluate how well JNJ-79635322 works when compared with teclistamab.

Enrolling
Multiple Myeloma
Drug: Teclistamab
Drug: JNJ-79635322

The purpose of the study is to compare the efficacy of talquetamab subcutaneous(ly) (SC) in combination with daratumumab SC and pomalidomide (Tal-DP)...

Active, not recruiting
Multiple Myeloma
Drug: Talquetamab
Drug: Dexamethasone

The purpose of this study is to evaluate the overall survival (length of time from the start of study to date of death from any cause) for pasritamig...

Enrolling
Metastatic Castration-resistant Prostatic Neoplasms
Biological: JNJ-87189401
Biological: Pasritamig

The purpose of this study is to demonstrate superiority of macitentan 75 milligrams (mg) in prolonging the time to the first clinical events committe...

Active, not recruiting
Pulmonary Arterial Hypertension
Drug: Placebo
Drug: Macitentan 75 mg

Trial sponsors

Janssen (J&J Innovative Medicine) logo
Actelion Pharmaceuticals logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems